ESL News and Press, Esterline Technologies Corporation From 10/10/18

NVCN +66%  on FDA grants Breakthrough Device designation to Neovasc's Reducer. More news on: Neovasc Inc., Novelion Therapeutics, Inc., Esterline Technologies Corporation, Stocks on the move, , Top stock market news, Read more ...

Shares of both companies will halted on news. More news on: TransDigm Group Incorporated, Esterline Technologies Corporation, Merger & acquisition news, Stocks on the move, Top stock market news, Read more ...

TransDigm Group (NYSE: TDG ) will purchase all of the outstanding shares of common stock of Esterline Technologies (NYSE: ESL ) for $122.50 per share in cash, which represents a premium of 38% to Esterline’s closing price on October 9 or a total transaction value of ~$4B. More new...

CLEVELAND and BELLEVUE, Wash. , Oct. 10, 2018 /PRNewswire/ -- TransDigm Group Incorporated (NYSE: TDG) and Esterline Technologies Corporation (NYSE: ESL) announced today that they have entered into a definitive agreement under which TransDigm will purchase all of the outstanding shares ...

NEW YORK, Oct. 08, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Suburban Propane Partners, L.P. (NYSE:SPH), National HealthCare Corpor...

The following slide deck was published by Esterline Technologies Corporation in conjunction with their 2018 Q3 earnings Read more ...

Esterline Technologies Corp. (ESL) Q3 2018 Earnings Call August 02, 2018 5:00 pm ET Executives John B. Hobbs - Esterline Technologies Corp. Curtis C. Reusser - Esterline Technologies Corp. Stephen M. Nolan - Esterline Technologies Corp. Analysts Sheila Kahyaoglu - Jefferies...

Esterline Technologies (NYSE: ESL ): Q3 EPS of $1.00 beats by $0.15 . More news on: Esterline Technologies Corporation, Earnings news and commentary, Read more ...